查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1866358

心电图（ECG）设备市场 - 全球预测（2025-2030年）

Global Electrocardiogram (ECG) Machine Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

心电图 (ECG) 设备市场预计将从 2025 年的 73.21 亿美元成长到 2030 年的 92.42 亿美元，复合年增长率为 4.77%。

受心血管疾病 (CVD) 发病率上升、人口老化以及携带式监测技术进步的推动，全球心电图 (ECG) 设备市场预计将呈现强劲增长。心电图设备，包括静态心电图、动态心电图和心电图监测，能够非侵入性记录心臟的电活动，从而实现对异常情况的早期检测。肥胖率上升和文明病风险增加，导致人们对持续心臟监测的需求不断增长，这推动了市场的发展。携带式和家用设备等技术创新提高了监测的可近性，使患者能够远端监测心臟健康，从而减少了频繁就医的需要。主要企业的大量研发投入正在推动先进、无故障系统的开发，进一步促进市场扩张。

市场驱动因素

心血管疾病发生率增加

全球心血管疾病（CVD）负担日益加重，成为推动心电图监测广泛应用的成长要素，尤其是在诊断和治疗方面。作为首要死因，心血管疾病凸显了对可靠心臟评估工具的需求。这一趋势推动了临床和家庭环境中对心电图设备的需求，随着医疗机构优先考虑预防性和持续性监测以降低心臟病相关风险，心电图设备的市场渗透率也随之提高。

老年人口的成长

根据联合国估计，到2050年，全球老年人口预计将达到15亿，这将显着推动市场成长。老年人罹患心臟病的风险更高，需要定期进行心电图监测以确保及时干预。这种人口结构变化导致心臟评估数量增加，从而推动了对适用于老年人的易用型携带式心电图解决方案的需求。

市场区隔与区域展望

按类型划分，心电图监测预计将引领市场，其便携性和在医院外长时间连续记录心臟活动的能力备受青睐。按终端用户划分，医院占据较大份额，这主要得益于大量需要心电图支持的心血管疾病相关治疗和手术。按地区划分，亚太地区预计将呈现最高的复合年增长率，这主要得益于日本和印度等国家医疗基础设施投资的增加以及人口老化。北美凭藉着成熟的医疗生态系统和主要製造商的存在，保持着显着的市场地位。

市场限制

不利的报销政策构成重大挑战，因为许多保险公司和医疗机构不承保心电图检查，导致病人难以负担。这种抵触情绪可能会阻碍心电图检查的普及，尤其是在那些没有全面保险的人群中，并有可能限制其在已开发市场和新兴市场的市场渗透率和成长。

竞争格局

主要市场领导包括飞利浦电子、Cardiocom Solutions、Seeler AG、工业、Mortara Instruments、通用电气和Biotelemetry。这些公司正透过推出新产品、併购策略来强化产品系列，维持竞争优势。重点领域包括开发整合人工智慧的心电图系统，以提高准确性和增强远端功能。

市场展望

预计到2030年，心电图市场将持续成长，主要驱动力包括心血管疾病（CVD）的流行、人口结构变化以及技术的便携性。亚太地区的快速成长与北美地区长期占据的主导地位形成鲜明对比，凸显了家庭监测领域创新发展的机会。为了满足日益增长的便捷心臟诊断需求，并确保在不断变化的医疗需求中得到更广泛的应用，行业相关人员必须透过倡导和成本优化策略来解决报销障碍。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

5. 全球心电图 (ECG) 设备市场（按组件划分）

  • 介绍
  • 硬体
  • 软体
  • 服务

6. 全球心电图 (ECG) 设备市场（按类型划分）

  • 介绍
  • 静止心电图
  • 携带式心电图仪
  • 压力心电图
  • 其他的

7. 全球心电图 (ECG) 设备市场（依导极类型划分）

  • 介绍
  • 单引脚型
  • 3 引脚型
  • 6 引脚型
  • 12 线型

8. 全球心电图 (ECG) 设备市场（依最终用户划分）

  • 介绍
  • 医院
  • 门诊手术中心
  • 其他的

9. 全球心电图 (ECG) 设备市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 台湾
    • 其他的

第十章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十一章：公司简介

  • GE Healthcare
  • Koninklijke Philips NV
  • CardioComm Solutions, Inc
  • SCHILLER AG
  • Nihon Kohden Corporation
  • Baxter International
  • OSI System Inc.
  • Fukuda Denshi Co., Ltd.
  • Allengers
  • VectraCor

第十二章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061611215

The Electrocardiogram (ECG) Machine Market is set to increase from USD 7.321 billion in 2025 to USD 9.242 billion by 2030, at a CAGR of 4.77%.

The global electrocardiogram (ECG) machine market is poised for robust growth, driven by the escalating prevalence of cardiovascular diseases (CVDs), an aging population, and advancements in portable monitoring technologies. ECG machines, including resting ECG, stress ECG, and Holter monitors, provide non-invasive recordings of the heart's electrical activity, enabling early detection of abnormalities. The market benefits from increasing demand for continuous cardiac monitoring amid rising obesity rates and lifestyle-related risks. Technological innovations, such as handheld and home-use devices, enhance accessibility, allowing patients to monitor heart health remotely, reducing the need for frequent hospital visits. Substantial R&D investments by key players are fostering error-free, advanced systems, further propelling market expansion.

Market Drivers

Increasing Incidence of Cardiovascular Diseases

The rising global burden of CVDs is a primary growth catalyst, necessitating widespread ECG monitoring for diagnosis and management. As the leading cause of mortality, CVDs underscore the demand for reliable cardiac assessment tools. This trend amplifies the need for ECG machines in clinical and home settings, driving market adoption as healthcare providers prioritize preventive and ongoing surveillance to mitigate risks associated with heart conditions.

Expanding Geriatric Population

The global geriatric population, projected by the United Nations to reach 1.5 billion by 2050, significantly fuels market growth. Older individuals are at higher risk for cardiac issues, requiring regular ECG monitoring to ensure timely interventions. This demographic shift increases the volume of cardiac evaluations, boosting demand for user-friendly, portable ECG solutions tailored to aging populations.

Market Segments and Geographical Outlook

By type, Holter monitors are expected to dominate, valued for their portability and ability to record continuous heart activity over extended periods outside hospital environments. By end-user, hospitals hold a substantial share, driven by the high volume of CVD-related treatments and surgeries requiring ECG support. Geographically, the Asia-Pacific region is anticipated to exhibit the highest compound annual growth rate (CAGR), supported by rising investments in healthcare infrastructure and a growing geriatric demographic in countries like Japan and India. North America maintains a notable market position, bolstered by a mature healthcare ecosystem and presence of leading manufacturers.

Market Restraints

Unfavorable reimbursement policies pose a significant challenge, as many insurers and providers do not cover ECG procedures, rendering them cost-prohibitive for patients. This reluctance can deter adoption, particularly among those without comprehensive coverage, potentially limiting market penetration and growth in both developed and emerging regions.

Competitive Landscape

Key market leaders include Koninklijke Philips N.V., CardioComm Solutions, Inc., SCHILLER AG, Nihon Kohden Corporation, Mortara Instrument, General Electric Company, and BioTelemetry, Inc. These players pursue strategies such as product launches, mergers, and acquisitions to enhance their portfolios and maintain competitive advantages. Focus areas include developing integrated, AI-enhanced ECG systems for improved accuracy and remote capabilities.

Market Outlook

The ECG machine market is set for sustained expansion through 2030, propelled by CVD prevalence, demographic trends, and technological portability. Asia-Pacific's rapid growth contrasts with North America's established dominance, highlighting opportunities for innovation in home-based monitoring. Industry stakeholders must address reimbursement hurdles through advocacy and cost-optimization strategies to fully capitalize on the rising demand for accessible cardiac diagnostics, ensuring broader adoption amid evolving healthcare needs.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Component

  • Hardware
  • Software
  • Services

By Type

  • Resting ECG Machine
  • Portable ECG Machine
  • Stress ECG Machine
  • Others

By Lead Type

  • 1-Lead
  • 3-Lead
  • 6-Lead
  • 12-Lead

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY COMPONENT

  • 5.1. Introduction
  • 5.2. Hardware
  • 5.3. Software
  • 5.4. Services

6. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY TYPE

  • 6.1. Introduction
  • 6.2. Resting ECG Machine
  • 6.3. Portable ECG Machine
  • 6.4. Stress ECG Machine
  • 6.5. Others

7. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY LEAD TYPE

  • 7.1. Introduction
  • 7.2. 1-Lead
  • 7.3. 3-Lead
  • 7.4. 6-Lead
  • 7.5. 12-Lead

8. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Others

9. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. GE Healthcare
  • 11.2. Koninklijke Philips N.V.
  • 11.3. CardioComm Solutions, Inc
  • 11.4. SCHILLER AG
  • 11.5. Nihon Kohden Corporation
  • 11.6. Baxter International
  • 11.7. OSI System Inc.
  • 11.8. Fukuda Denshi Co., Ltd.
  • 11.9. Allengers
  • 11.10. VectraCor

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations